Detalles de la búsqueda
1.
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02).
Oncologist
; 24(11): e1115-e1122, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31235483
2.
Factors related with symptom duration until diagnosis and treatment of symptomatic colorectal cancer.
BMC Cancer
; 13: 87, 2013 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-23432789
3.
Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol.
BMC Cancer
; 10: 528, 2010 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-20920369
4.
Metastatic Colorectal Cancer. First Line Therapy for Unresectable Disease.
J Clin Med
; 9(12)2020 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33265959
5.
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
JCO Precis Oncol
; 3: 1-16, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35100697
6.
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
Neoplasia
; 20(7): 678-686, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29842993
7.
Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
Eur J Cancer
; 41(15): 2241-9, 2005 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-16214045
8.
Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinoma.
Int J Radiat Oncol Biol Phys
; 62(1): 91-6, 2005 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15850907
9.
Phase II study of irinotecan (CPT-11) administered every 2 weeks as treatment for patients with colorectal cancer resistant to previous treatment with 5-fluorouracil-based therapies: comparison of two different dose schedules (250 and 200 mg/m2) according to toxicity prognostic factors.
Anticancer Drugs
; 15(9): 835-41, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15457123
Resultados
1 -
9
de 9
1
Próxima >
>>